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ABSTRACT
Restriction Modification (RM) systems prevent the in-
vasion of foreign genetic material into bacterial cells
by restriction and protect the host’s genetic mate-
rial by methylation. They are therefore important in
maintaining the integrity of the host genome. RM
systems are currently classified into four types (I to
IV) on the basis of differences in composition, target
recognition, cofactors and the manner in which they
cleave DNA. Comparing the structures of the differ-
ent types, similarities can be observed suggesting
an evolutionary link between these different types.
This work describes the ‘deconstruction’ of a large
Type I RM enzyme into forms structurally similar to
smaller Type II RM enzymes in an effort to elucidate
the pathway taken by Nature to form these different
RM enzymes. Based upon the ability to engineer new
enzymes from the Type I ‘scaffold’, an evolutionary
pathway and the evolutionary pressures required to
move along the pathway from Type I RM systems to
Type II RM systems are proposed. Experiments to
test the evolutionary model are discussed.
INTRODUCTION
Prokaryotic restriction-modification (RM) systems provide
a major defence against invading foreign DNA (1–4) and as
such their genes are found in over 96% of bacterial genomes
and over 99% of archaeal genomes (5,6). A typical RM
system (7–12) includes a restriction endonuclease (REase),
whose cleavage of DNA is triggered by the recognition
of a specific DNA sequence on foreign DNA. The other
constituent part of the RM system is a methyltransferase
(MTase), whose action prevents cleavage of host DNA by
methylating the target DNA sequence. Given their signifi-
cant role in protecting the host cell, it is surprising that RM
systems are not essential to prokaryotic life. As such, RM
systems should be viewed as necessary for the survival of
the population, and not the individual cell; RM activity is
the main method to prevent the spread of foreign DNA in
a population (1,3,11,13–16) although additional roles have
been proposed (3).
In some cases, RM functions are carried out by separate
REase andMTase enzymes.However, inmany systems both
of these activities are fulfilled by a multi-subunit protein or
even a single polypeptide (7,17). Hence, the RM systems
show great variety in protein structure and gene sequence.
To date, there are three classes of RM systems (Types I to
III) and one class operating only on methylated DNA and
thus lacking the modification function while retaining the
restriction function (Type IV). These Types are separated
due to differences in composition, target recognition, co-
factors and the manner in which they cleave DNA (18). The
defining characteristic of Type II RM systems, and perhaps
the most important in terms of their use to molecular bi-
ology, is that their REase cleaves double stranded DNA at
fixed, easily identified positions at or near to the target se-
quence (19).
Type I RM enzymes and their structural malleability
Type I systems were the first RM systems to be discovered
(7,8,19). They are large hetero-oligomeric complexes, which
perform cleavage of DNA away from their recognition site,
in anATP-dependent reaction (8,20–24), Figure 1A.AType
I restriction enzyme is composed of three separate sub-
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Figure 1. (A) A cartoon comparison of the domain structures encoded by Type I, Type IIB and IIG RM systems. The HsdR subunit contains three key
domains, the N terminal nuclease (red), and the motor domain (dark pink) and tail region (light pink). The HsdM subunit contains three domains, the N
terminal (green), the catalytic (blue), and a tail region (grey). The HsdS subunit is composed of two target recognition domains (TRDs, yellow and red),
which are linked by regions of conserved sequence (‘CR’, orange). Structures derived by X-ray crystallography and modelling (24), are shown with the
same domain-specific colouring (not to scale). The same colour scheme is used for the domains in Type IIB and IIG RM systems. (B) In this work, the
fusion of the Nuclease domain of HsdR to the N-terminus of the HsdM is investigated. (C) Further domain re-arrangements between the HsdM and HsdS
are also investigated in this work.
units. These subunits are denoted by Hsd (host specificity
for DNA) R for the restriction subunit (∼130 kDa), M
for the MTase subunit (∼60 kDa), and S for the sequence-
recognition specificity subunit (∼50 kDa). The ∼440 kDa
restriction complex has a R2M2S1 stoichiometry, whilst a
M2S1 stoichiometry acts as a cognate MTase for the sys-
tem. Type I enzymes use energy from ATP hydrolysis to
translocate DNA. The HsdR subunit binds both ATP and
Mg2+ in order to perform the complicated process involved
in producing double strand breaks in unmethylated DNA.
The Type I enzyme binds its recognition sequence and the
motor domains in the HsdR reel the DNA in towards the
enzyme and cutting occurs when two HsdR motors collide.
This can occur at anything from 40 bp to many kb away
from the recognition site but is generally about half way be-
tween one site and the next target site.
Specific DNA sequences are recognised by the HsdS
subunit (22–27). For the most part, these sequences pos-
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sess the same general organisation of three specific nu-
cleotides followed by a variable spacer of five to eight non-
specific nucleotides (N), and then a further three to four
specific nucleotides. For example, the target sequence of
SauSTORF499P from Staphylococcus aureus clonal com-
plex CC398 is ACC(N)5RTGA (26). The S subunit con-
tains two target recognition domains (TRDs), separated by
a central domain, which is conserved in members of the
same family (20,25–27). The N-terminal TRD is specific
for the 5′ part of the bipartite DNA sequence, while the
C-terminal TRD recognises the 3′ part. The central con-
served domain serves to coordinate interactions with the
other subunits andmore importantly, to separate the TRDs
to a defined distancematching the length of the non-specific
DNA spacer in the target sequence (20). The presence of
additional N terminal and C terminal conserved domains,
which together match the sequence of the central conserved
domain, indicated a circular arrangement of the structure
(28–32) which was confirmed by crystallography (33–35).
Alterations to the TRDs, which are encoded by the
hsdS gene, can establish a new DNA specificity. TRDs
may be swapped, truncated, switched and the number of
non-specific nucleotides can be increased by extending the
conserved sequence separating the two TRDs to engineer
new specificity (25–27,36–40). Not only do the hsdM and
hsdS genes share the same promoter but their open reading
frames overlap at the junction created by the end of hsdM
and the start of hsdS (41). Hence, the subsequent transla-
tion is coupled and during translation, a jump is required
to create the two separate polypeptides. Roberts et al. were
able to remove this frameshift from the MTase genes of the
EcoKI Type I enzyme to create a fusion of the M and S
subunits (42). This protein product showed full RM activ-
ity in vivo andwas also successfully over-expressed and puri-
fied.With the addition of stoichiometric amounts of EcoKI
HsdM protein, the purified fusion formed an active restric-
tion complex in vitro.
Type II RM enzymes and their classification
The most well-known and commonly used Type II REases
fall into the subcategory of Type IIP as they bind and
cleave palindromic sequences. The Type IIP REases, such
as EcoRI and BglI, are ‘Orthodox’ ∼60 kDa homodimeric
complexes, which cleave within or next to their recogni-
tion sequence (12,18). The associated MTases are usually
thought of as monomers of∼30 kDa although at least some
function as dimers (17,43,44). Not all of the Type II RM
systems conform to the narrow definition of Type IIP sys-
tems, and so they are separated into other sub-categories
(18), Figure 1A. The factors that differentiate the many
Type II sub-types are: the nature of the recognition se-
quence, tertiary and quaternary structure, and the type of
cut produced on DNA. Type IIB systems have a subunit or-
ganization and activity not unlike Type I systems although
they lack the ATP-dependent DNA-translocating motors
(45,46). They possess REase, MTase and two TRDs in one
enzyme, and can methylate either symmetric or asymmet-
ric sequences which are indistinguishable from the targets
recognised by the Type I RM systems. They cleave DNA in
a SAM-dependent reaction and do so either side of their
recognition sequence resulting in the removal of a short
fragment. In effect they are ‘motor-less’ Type I RM sys-
tems. Like many Type IIB systems, IIG REases also encode
REase, MTase and a single TRD in a single polypeptide.
They are effectively half of a Type IIB RM enzyme or half
of a ‘motor-less’ Type I RM system (47–49), Figure 1A.
RM enzymes with similarity to Type I RM enzymes
In addition to the Type IIB and IIG RM systems discussed
above, additional naturally-occurring, evolutionary inter-
mediates between Type I and II systems are known. The
Type ISP family possess all the functions of a Type I en-
zyme including the ATP-dependent motor, within a sin-
gle polypeptide (SP) (50–52). The single TRD in a Type
ISP system recognises a 6–7 bp asymmetrical target. They
perform ATP-dependent dsDNA translocation and cleav-
age, and SAM-dependent modification. Type III RM en-
zymes are ATP-dependent hetero-oligomeric enzymes pos-
sessing REase and MTase in a single complex with a ‘res’
REase subunit and a ‘mod’ MTase subunit containing a
well-defined TRD (9,53). The motor domain in the res sub-
unit facilitates diffusion of the enzyme on the DNA rather
than the directed translocation driven by the motor domain
in the Type I HsdR subunits but the domains have the same
evolutionary origin (53). There are also RM systems known
colloquially as ‘Type one and a half’ systems comprised of
a Type IIP REase and a Type IMTase (7) andmore recently
the structure of a Type IIP REase with a striking similarity
to a Type I HsdS subunit has been determined (54).
Evolution of RM enzymes
This work aims to investigate the hypothesis that Type I,
Type II and Type III RM systems are evolutionarily linked.
Bymaking step-wise alterations to the subunits of the SauS-
TORF499P CC398-1 Type I RM system from S. aureus
(15,25–27), active enzymes with novel specificities have been
successfully engineered. Soluble fusions of the nuclease do-
main from HsdR to HsdM, HsdM to HsdS and HsdM to
half-HsdS were produced. These new protein structures are
comparable to Type II RM systems.
This leads us to propose a structural model for the evolu-
tion of RM systems which attempts to answer the following
questions:
1. When did RM first appear?
2. Why did it appear?
3. What did the first RM system look like?
4. Why did it subsequently evolve to form the large range
of RM variants observed today?
5. What was the evolutionary pathway?
MATERIALS AND METHODS
Chemicals, bacterial strains and phage
All chemicals were purchased from Sigma-Aldrich unless
otherwise stated.
Bacterial strain Escherichia coli NM1261 (rK−mK+) was
used for assays for in vivo activity (27). Bacterial strains E.
coli BL21 (DE3) (hsdSB) and DH5 (hsdR17 rK−mK+)
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were from New England Biolabs (Ipswich, MA). Bacterial
strain E. coli ER2796, a kind gift from Dr E. Raleigh (New
England Biolabs), was used in the SMRT sequencing proto-
col (55).E. coliER2796 is a derivative ofE. coliK12with the
phenotype λ-fhuA2 Δ(lacZ)r1 glnV44 mcr-62 trp-31 dcm-
6 zed-501::Tn10 hisG1 argG6 rpsL104 dam-16::Kan xyl-7
mtlA2 metB1 (mcrB-hsdK-mrr)114::IS10 lacking all host
DNA methylation systems (55).
The pJF118His plasmid for expression of all genes has
been previously described (27). Recombinant plasmids were
isolated from transformed E. coli DH5 cells and the de-
sired DNA sequences were confirmed. The amino acid se-
quences of the HsdR, HsdM and HsdS used in this work
are given in Supplementary Table S1.
Fusions of the DNA encoding the nuclease do-
main of HsdR to the 5′ end of hsdM were created
using PCR. The first RM fusion gene was created in
a PCR using the oligonucleotides, ‘Mu50nucuni TS’
(5′-AGTCAGTCAGGGATCCAAGAAGGAGATAT
ACATATGGCATACCAAAGTGAATACGC-3′) and
‘Mu50nucendalpha-CC398-1BS’ (5′-CGTTGTTTTTC
AGTAATAGACATATTATTCCCTGTCTCAGTCG-3′),
with the template hsdR gene (SauN315ORF189P) pre-
viously ligated into pRSFDuet-1 (Novagen) (27). The
second PCR was conducted using the oligonucleotides,
‘Mu50nucendcoil-CC398-1TS’ (5′-CGACTGAGACAGG
GAATAATATGTCTATTACTGAAAAACAACG-3′)
and ‘C398-1BS’ (5′-GATCGAATTCCGGATCCAATA
AACATCTTTTGAAGTAATGAC-3′), with the wild-type
CC398-1 MTase genes in pJF118His vector as template
(27). Further hsdR to hsdM fusion constructs were created
using the same outer primers (‘Mu50nucuni TS’ and
‘CC398-1BS’) and specific primers for the different regions
of hsdR, to which the hsdR portion of the fusion would
be truncated. The fusion constructs, the primers used
to create them in PCR and their amino acid sequences
are summarised in Supplementary Table S2. The fusion
proteins retain the methionine encoded by the ATG codon
at the start of hsdM. The gene sequences used as a source
for this work are SauN315ORF189P, M.SauSTORF499P
and S.SauSTORF499P from REBASE (6).
To create the CC398-1 MS fusion gene encoding the
protein ‘MSfus’, the hsdM open reading frame was fused in
frame to hsdS by the polymerase chain reaction (PCR) and
the resulting product was ligated into the pJF118His vec-
tor. PCR using oligonucleotides ‘HsdM-TS’ (5′-GATCG
ATCGGATCCAAGAAGGAGATATACATATGTC-3′)
and ‘MTasefusion-BS’ (5′-GCACATTTTTCTTTTGT
GTATTACTCATCTCATCTTTCAACACCCCAAG-3′),
with the wild-type CC398-1 MTase genes in pJF118His
as template, generated a fragment comprising the 5′
UTR upstream of hsdM and the entire hsdM ORF, fused
in frame with the first 28 bases of hsdS. A PCR with
a second pair of oligonucleotides, ‘MTasefusion-TS’
(5′-CTTGGGGTGTTGAAAGATGAGATGAGTAA
TACACAAAAGAAAAATGTGC-3′) and ‘CC398-1BS’
(5′-GATCGAATTCCGGATCCAATAAACATCTTTT
GAAGTAATGAC-3′), with the wild-type CC398-1MTase
genes in pJF118His as template, generated a fragment com-
prising the last 29 bases of hsdM fused to the entire ORF
of hsdS. These two PCR products were purified and fused
in a reaction primed with oligonucleotides ‘HsdM-TS’
and ‘CC398-1BS’. The resulting product was purified and
digested with BamHI. pJFMS was digested with BamHI,
treated with Calf Intestinal Phosphatase and then ligated
with the PCR product.
To create the ‘Half S’ MTase ‘M1/2S’, hsdS was truncated
at the end of the central conserved region, directly before the
start of the second TRD (equivalent to amino acid D220).
PCR was performed with primers ‘HsdM-TS’ and ‘CC398-
1 TRD 1 BS2’ (5′-GATCGAATTCCGGATCCATCT
TTACCATTCTCATCTTTAAATCG-3′) with wild-type
CC398-1MTase genes in pJF118His as template. The prod-
uct of this reaction was subjected to agarose gel elec-
trophoresis and the band of the expected size was excised,
gel eluted, BamHI digested and then ligated into vector
pJF118His. The hsdM to half hsdS fusion gene to produce
the protein ‘M1/2Sfus’ was made in the same way but with the
fused MTase genes in pJF118His in the PCR.
The amino acid sequences of these constructs are given
in Supplementary Table S3. The fusion proteins retain the
methionine encoded by the ATG codon at the start of hsdS.
Bacterial genome singlemolecule real-time (SMRT) sequenc-
ing
Non-methylating (dam− dcm−) E. coli ER2791 competent
cells were transformed with a plasmid containing the tar-
get MTase and spread on a plate of lysogeny broth (LB)
agar (25). Agar plates were supplemented with 100 g/ml
carbenicillin, which acted as a selection marker for the ex-
pression construct. Plates were incubated at 37◦Covernight.
A colony of successful transformants was picked into 5
ml of LB supplemented with 100 g/ml carbenicillin and
incubated overnight at 37◦C whilst shaking. Cells from
the subsequent culture were separated into 1 ml aliquots
and harvested by centrifugation at 2380 x g for 15 min-
utes at 4◦C. The Wizard Genomic DNA Purification Kit
(Promega, Madison, WI, USA) was then used to lyse the
cells and purify the genomic DNA. The quality of the ge-
nomic DNA preparations was initially assessed by agarose
gel electrophoresis and from the shape of the absorbance
profile from 240 to 340 nm. The DNA library for SMRT
sequencing was prepared and subsequently analysed using
a Pacific Biosciences sequencer as described in Anton et al.
(55).
Gene expression and purification of proteins
Overexpression of all genes was carried out in E. coli BL21
(DE3) competent cells, which were transformed with the
plasmid expressing the target gene. Induction of expres-
sion was performed by adding IPTG to 1 mM and further
growth at 20◦C overnight (∼18 h).
All proteins were expressed with a hexa-HisTag attached
to the C-terminus of the HsdS part of the protein. Af-
ter overexpression of target genes, the E. coli BL21 (DE3)
cell pellets were resuspended in 20 mM sodium phosphate
buffer with 500 mM NaCl (pH 7.5), 20 mM Imidazole and
a dissolved EDTA-free protease inhibitor tablet (Roche), in
a 1:10 (g: ml) ratio. The cells were then disrupted by sonica-
tion using a Soniprep 150 sonicator (Sanyo, Tokyo, Japan),
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fitted with a 9mm diameter probe for ∼20 minutes with in-
termittent cooling. Cells were then centrifuged at 7700 x g
for ∼45 min at 4◦C. The supernatant was filtered through
a filter unit (0.45 um; Sartorius AG, Goettingen, Germany)
and then applied to a pre-equilibrated Histrap FF 5 ml col-
umn (GE Healthcare) at a flow rate of 100 ml/hr. The flow-
through was collected. The column was then washed with
100 ml 20 mM Imidazole buffer and the flow-through was
collected. This was followed by an elution of the protein
with ∼10 ml of buffer supplemented with 500 mM imida-
zole, discarding the first 3 ml and collecting the next 6 ml.
This was then concentrated to ∼4 ml, using a 20 ml 30 000
MWCO Vivaspin concentrator (Sartorius).
The 500 mM imidazole-containing buffer was removed
from the sample by buffer exchange. This was performed
using a PD-10 desalting column (GEHealthcare). The pro-
tein sample was concentrated to 2.5 ml and loaded on to the
PD-10 column equilibrated with 20 mMTris–HCl pH 8, 10
mM MgCl2, 500 mM NaCl and 7 mM 2-mercaptoethanol
buffer. After elution, sample concentration was determined
by anA280 reading. Part of the sample was immediately used
in an assay to determine presence of DNA cleavage activity
and the remainder concentrated in the Vivaspin concentra-
tor (Sartorius). Samples were stored at -20◦C after the ad-
dition of glycerol to 50% (v/v).
All HPLC analytical size exclusion runs were carried out
using a BioSep-SEC-S 3000 (Phenomenex) column and a
pH 6.5 buffer (20 mM Tris, 20 mM MES, 10 mM MgCl2,
200 mMNaCl, 0.1 mMEDTA, 7 mM 2-mercaptoethanol).
This buffer was used to dilute the samples to a concentra-
tion of approximately 4 M, 50 l of which were then in-
jected onto theHPLC system for each run.A flow rate of 0.5
ml/minwas used for each run, which took approximately 10
min to complete. The absorbance at 280 nm was monitored
and recorded by a data logger. The column was calibrated
using several protein standards (Sigma Aldrich) of various
concentrations, and a calibration curve was produced.
Assessment of RM activity in vivo
The methods employed for assaying RM activity in vivo
used the efficiency of plating (eop) of phage v prepared
from either a strain lacking the MTase genes to obtain un-
modified phage or a strain transformed with the MTase
plasmid to obtain modified phage have been previously de-
scribed (56,57). All assays were performed in triplicate ei-
ther as spot tests (nuclease domain fusions) or as full plate
tests (MS fusions). The spot tests are suitable when restric-
tion is absent and the whole plate tests are required when
restriction is present to better quantify the degree of restric-
tion. The spot tests used for assaying the nuclease fusions
often give a standard deviation of ∼30% so a value of eop
greater than one can occur (56). The promoter on the ex-
pression plasmids is slightly leaky so IPTGwas not required
to be added to the plates.
In vitro DNA cleavage assay
Assays were conducted by incubating the enzyme under
investigation with a library of plasmids. These plasmids
were created by the ligation of known DNA sequences be-
tween EcoRI and BamHI sites of pUC19. The plasmids
in the library were based on the DNA sequence of phage
PhiED1 (a gift from Garry Blakely, University of Edin-
burgh). These plasmids are numbered sequentially from 1E
to 20E (omitting 3E and 8E). The plasmid and specific in-
sert sequences of these plasmids have been described previ-
ously (27) and are given again in the Supplementary Table
S4. Each plasmid contains a ∼2.4 kb insert that was PCR
amplified from Bacteroides fragilis phage PhiED1, ligated
into vector pUC19. Collectively, the 18 plasmids contain
>40 kb of known sequence and comparing their suscepti-
bility to cleavage allows inference of REase specificity (27).
MTases under investigation were supplemented with R sub-
unit from S. aureus CC5 and incubated with the plasmid li-
brary in separate reactions. Reaction digests had a total vol-
ume of 50 l and a typical digest was prepared using 5 l
of 10× NEBuffer 4 [New England Biolabs; 50 mM potas-
sium acetate, 20 mM Tris–acetate, 10 mM magnesium ac-
etate, 1 mM dithiothreitol (pH 7.9)], 2 mM ATP, 0.64 mM
S-adenosyl-L-methionine, 0.01mg of bovine serumalbumin
and 10 l of the enzyme stock. The enzyme stock was pre-
pared in a volume of 50 l with 5 l of 10× NEBuffer 4
with final concentrations of 1.16 M R subunit and 0.42
M MTase, thus ensuring an excess of R over the MTase
to give formation of the R2M2S1 RM enzyme. Incubations
were left for 12min in awater bath set at 37◦C.The reactions
were stopped by the addition of Proteinase K (Roche) and
incubated in a 60◦C water bath for 25 min. Samples were
then analyzed by agarose gel electrophoresis. Cleavage sites
are distant from the target site for these enzymes; therefore,
a computer program, RMsearch, was used to search for tar-
get sequences present in plasmids cut by the enzyme and not
present in uncut plasmids (58).
RESULTS
The four variants of the CC398-1 SauSTORF499P Type I
RM system shown in Figure 1B and C were constructed.
The nuclease fusion had ten subvariants with differing
lengths of the 5′ end of hsdR fused to the 5′ end of hsdM as
shown in Supplementary Table S2. These different lengths
were chosen by comparison of the sequence of HsdR with
the known sequence and structure of theHsdRprotein from
the EcoR124I RM system (59,60), Supplementary Figure
S1. This process was informed by secondary sequence pre-
dictions and a protein model, created by the Phyre2 online
software (61).
Two subvariants of the M1/2S protein were engineered
with the full length hsdM followed by the first 666bp or
639bp of hsdS. The longer sequence from hsdS encodes all
of the central conserved region of HsdS. The M1/2Sfus con-
struct contained the first 666bp of hsdS fused in frame to
hsdM.
In vivo analysis of restriction and modification activity using
phage 
The in vivo assay detecting restriction and modification of
 phage is a simple way to assess the activity of the variants
of the CC398-1 RM system. Efficiency of plating (eop) of
phage  is the ratio of phage titre on a restricting strain ver-
sus a non-restricting strain: in this case a strain transformed
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with two plasmids, one for HsdR and one for the MTase,
versus the same strain transformed with the MTase plas-
mid. The strain containing the ‘wild-type’ CC398-1 MTase
plus the HsdR showed nearly a ten-fold reduction in eop
and is therefore active in restriction, Table 1.
No significant change in eop from a value of one (values
range from 0.5 to 2.25) was observed in strains expressing
any of the ten nuclease-HsdM fusions along with HsdS, Ta-
ble 1, indicating that none of these fusions possess restric-
tion activity. However, phage recovered from these assays
had all becomemodified as shown by the titre of these phage
on the strain harbouring the wild-type CC398-1 MTase +
HsdR compared to their titre on a strain lacking HsdR, Ta-
ble 1. This indicates that these fusions are active in modi-
fication and have the same sequence specificity as the wild-
type system. However as described in the next section, the
protein instability noted during purification may also be
present in vivo so the modification activity may be due to
an assembly without the nuclease domain, a possibility that
is difficult to rule out at present.
In the presence of HsdR, the M1/2S protein was only ac-
tive in modification but not restriction, Table 1. This is in
contrast to the situations found with other truncations of
the S subunit of Type I RM systems (28,29,31). This may
be due to protein instability as observed when purifying
this protein as described below. In contrast, bothMSfus and
M1/2Sfus in the presence of HsdR were active in both mod-
ification and restriction, Table 1. The apparent regaining
of restriction activity when comparing M1/2S with M1/2Sfus
is presumably due to an improved protein stability as dis-
cussed below as the amount of HsdR subunit being ex-
pressed in the cells should be the same.
Protein expression
In our attempts to make a Type IIB RM enzyme, only one
of the nuclease domain-HsdM fusions, RM EB 2 protein,
could be expressed and partially purified along with the
S subunit, Supplementary Figure S2. SDS-PAGE of frac-
tions from a size exclusion chromatography column indi-
cated that the HsdS initially coeluted with a small amount
of RM EB 2 (lane 4 in Supplementary Figure S2) followed
by coelution of HsdS with RM EB 2 and a ∼70 kDa frag-
ment (see lanes 6 to 8 in Supplementary Figure S2). This
was then followed by coelution of HsdS with RM EB 2
and a fragment of ∼61 kDa (see lanes 8 and 9 in Supple-
mentary Figure S2) and lastly by coelution of HsdS with
RM EB 2 and a fragment of ∼65 kDa (see lane 10 in Sup-
plementary Figure S2). As it is known that deletion of theC-
terminus of theHsdM subunit prevents assemblywithHsdS
(62) then these fragments of RM EB 2 must be deletions
of the N-terminal region and their size indicates that these
fragments have lost the nuclease domain. Thus, it appears
that RM EB 2 predominantly forms a complex of the form
RM EB 2 + truncated fragment + HsdS and this may ex-
plain the absence of nuclease activity in vivo as the complex
mostly contains only a single nuclease domain.
TheMSfus, M1/2S andM1/2Sfus fusions and truncations all
expressed well and were soluble, Supplementary Figures S3,
S4 and S5, respectively.Although it had a tendency to aggre-
gate with time, the M1/2Sfus protein was the purest of these
three proteins.
The MSfus protein was unstable during the purification
procedures and underwent some proteolysis. The addi-
tional bands on an SDS-PAGE gel were excised and sent
for analysis by peptide fragmentation mass spectrometry
at the Mass Spectrometry and Proteomics Facility (Uni-
versity of St. Andrews). Mass spectrometry results con-
firmed the larger of the contaminating species contained
a C-terminally clipped form of the MSfus species of ∼73
kDa and the smaller species was an unrelated E. coli pro-
tein (data not shown). The ∼73 kDa fragment comprises
all of HsdM and about half of the first TRD of HsdS. A
Sephacryl S200 size exclusion purification step was added
to the purification method, however the larger fragment re-
mained bound to the MSfus suggesting that a proportion of
the CC398-1 MSfus protein is copurified with the clipped
fragment.
Analysis of pooled protein fractions on a calibrated ana-
lytical size exclusion column showed a single major elution
peak for CC398-1 MTase, M1/2S and M1/2Sfus proteins with
apparent molecular masses of 241, 225 and 251 kDa respec-
tively, Supplementary Figure S6 and Supplementary Table
S5. The expected molecular masses for these proteins are
166 to 173 kDa assuming the forms M2S1, M2(1/2S)2 and
M(1/2Sfus)2 for these proteins. It has been previously noted
that Type I MTases elute with this higher than expected
molecular mass due to their highly non-spherical shape
(22,63–69). The M1/2S and M1/2Sfus proteins also showed
material eluting before the main protein peak indicating
the presence of very high molecular mass aggregates. As
noted above, the MSfus protein co-eluted with a proteolytic
fragment from the Sephacryl S200 column. The analytical
column showed a complex asymmetric elution profile with
the maximum UV absorption corresponding to a molecu-
lar mass of 325 kDa, Supplementary Figure S6. This higher
mass may indicate that the fusion protein can also exist as
a dimer (MSfus)2. The broadness of the elution profile may
also suggest monomeric fusion protein and the existence of
a complex equilibrium of different quaternary structures.
Plasmid cleavage activity in vitro
A set of plasmids containing inserts of known sequence was
used for cleavage assays. Conversion of closed circle, super-
coiled plasmid DNA to linear form was used as evidence
of cleavage. As previously noted, the introduction of single-
strand nicks into the plasmids to give an open circular form
is attributed to the presence of nuclease contaminants in our
enzyme preparations and is not evidence for the presence of
a target site (27). In addition, the MSfus enzyme produced a
small amount of linearised DNA with every plasmid used,
Figure 2 top row. However, in this case the absence or near
absence of closed circular DNA in plasmids containing the
target site was obvious and gave a target agreeing with the
results of SMRT sequencing.
The partially purified complex of nuclease-HsdM fusion,
RM EB 2, and S subunit showed no cleavage activity when
incubated with a plasmid containing a target site (data not
shown). This is in agreement with the in vivo results shown
in Table 1.
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Table 1. The in vivo restriction andmodification activity of the wild type CC398-1 Type I RM system and its derivatives assessed by the efficiency of plating
(eop) of phage v on E. coli strain NM1261 transformed with plasmids expressing CC398-1 (HsdR + HsdM + HsdS) or its derivatives (first column).
NM1261 has no RM activity overlapping with RM systems in this investigation. The first column also shows the length of the nucleotide sequences taken
from the 5′ end of the hsdR gene for fusion to the 5′ end of the hsdM gene, and the equivalent number of amino acids (aa), to make the RM EB X series of
fusions. Two versions of the M1/2S construct were tested. The second column shows the eop of phage infecting the strain transformed with the RM system
relative to the strain cotransformed with MTase and pRSFDuet-1 (the vector used for supplying hsdR). A low eop (∼0.1) indicates restriction proficiency.
The third column shows the eop of phage recovered from the experiments in the second column on reinfection of strains transformed with the RM system
relative to the strain cotransformed with MTase and pRSFDuet-1. A high eop (∼1) indicates modification proficiency
RM system
Eop of phage v on E. coli NM1261 expressing
the system
Eop of recovered phage v on E. coli NM1261
expressing the system
HsdR + HsdM + HsdS 0.15 0.88
HsdS + RM EB 2 (1–786, aa 1–262) 1.1 1.67
HsdS + RM EB 3 (1–651, aa 1–217) 0.68 0.8
HsdS + RM EB 4 (1–621, aa 1–207) 1.5 1.13
HsdS + RM EB 5 (1–645, aa 1–215) 2.25 1.06
HsdS + RM EB 6 (1–675, aa 1–225) 1.0 0.67
HsdS + RM EB 7 (1–732, aa 1–244) 2.0 1.0
HsdS + RM EB 8 (1–513, aa 1–171) 0.75 0.89
HsdS + RM EB 9 (1–549, aa 1–183) 1.25 0.8
HsdS + RM EB 10 (1–816, aa 1–272) 0.75 0.59
HsdS + RM EB 11 (1–855, aa 1–285) 0.5 1.25
HsdR + MSfus 0.09 0.78
HsdR + M1/2S (M1/2S shorter version) 0.58 (0.40) 0.75 (0.70)
HsdR + M1/2Sfus 0.10 1.02
Figure 2. Agarose gel electrophoresis analysis of samples from a plasmid cleavage assay using the ‘E’ series of plasmids described previously (27). From
top to bottom the gels show the effect of the purified HsdR incubated withMSfus, M1/2S andM1/2Sfus on the plasmid. The gels show three different plasmid
DNA species. The species that occurs at the top of each gel lane has a single strand cut and is ‘nicked’ (Ni). Below this is the linearised species, when both
strands have been cut by enzymatic activity (highlighted by green boxes). The lowest species is the uncleaved supercoiled DNA (SC). The lanes marked M
are molecular size markers (kb). Lanes marked 5E+ and 4E− are plasmids incubated with HsdR plus CC398-1 MTase that contain a single site or no site
for the RE and act as positive and negative controls, respectively.
The MSfus, M1/2S and M1/2Sfus proteins were all active
in cleavage when complemented with HsdR as shown in
Figure 2. Of note is that extra HsdM was NOT required
for MSfus to be active. This is in contrast to the MSfus
protein constructed from the EcoKI Type I RM system
which needed additional HsdM to be added to the reaction
(42). This is consistent with the identification of a fragment
of the fusion protein remaining associated with CC398-1
MSfus throughout protein purification. RMsearch analy-
sis showed recognition by MSfus of the wild-type CC398-1
RM enzyme target of ACCN6TGA as anticipated (26). The
1/2S proteins, M1/2S and M1/2Sfus recognise a different tar-
get, ACCN5GGT, which is palindromic and has a spacer
change resulting in the adenine targets being one base pair
further apart than for the wild type CC398-1 RM enzyme
(9 bp rather than 8 bp) even though the overall target se-
quence is one base pair shorter (11 bp rather than 12 bp).
The DNA cleavage activity of M1/2Sfus and M1/2S contrasts
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with the in vivo restriction activity, which was only clearly
observed forM1/2Sfus, suggesting an impaired association of
M1/2S with HsdR or too low an amount of HsdR being ex-
pressed in vivo.
Single-molecule real-time (SMRT) sequencing
SMRT sequencing is able to identify modified bases in se-
quenced DNA and can therefore be used to identify the
DNA recognition motif of a Type I MTase (e.g. (25,26)).
The method is particularly useful in that all modification is
conducted in vivo eliminating the need for large amounts of
purified protein.
The expression plasmids containing the wild-type
CC398-1MTase, MSfus, M1/2S andM1/2Sfus genes were used
to transform competent Escherichia coli ER2796 cells, a
strain with no inherent DNA methylation. Genomic DNA
was isolated from individual E. coli colonies expressing the
protein of interest. The results from SMRT sequencing,
Table 2 and Supplementary Figure S7, confirmed that
the manipulated MTase genes were expressing active
MTases in vivo in agreement with the results in Table 1 and
Figure 2. The DNA recognition sequence for MSfus was
ACCN5RTGA as expected although some methylation
of ACCN5RTGG was also detected. Analysis of M1/2S
and M1/2Sfus show the novel enzymes methylating the
palindromic sequence, ACCN5GGT. This finding also
confirmed that the M1/2S and M1/2Sfus dimerise to recognise
the palindromic target sequence.
DISCUSSION
By making step-wise alterations to the structure of the
CC398-1 Type I RM system, novel, soluble, sequence-
specific enzymes have been engineered. As previously as-
sumed from sequence comparisons (8), our results indicate
that the Type I RM enzymes are close relatives of the IIB
and IIG RM enzymes in terms of the organisation of their
structural domains.
Although not restriction active, fusions of the nuclease
domain of HsdR to the HsdM could be produced and puri-
fied in an assembly with the S subunit. Most of the purified
material is a complex of RM EB 2 with HsdS and a frag-
ment of RM EB 2 lacking the nuclease domain. This com-
plex retains methylation activity but lacks nuclease activity
suggesting that two nuclease domains are necessary. How-
ever, the successful expression and assembly of the fusion
protein with HsdS suggests that our approach eventually
could create a viable RM system, but that different lengths
of HsdR would need to be fused to HsdM and tested be-
fore a fully active analogue of a Type IIB RM enzyme is
obtained. To achieve full restriction and modification activ-
ity will require more optimisation but as the proteins are ex-
pressed, soluble and bind to the S subunit this is technically
feasible although probably very challenging.
Manipulation of the hsdM and hsdS genes proved more
successful and represents a step towards a Type IIG RM
system. Three variants with HsdM fused to HsdS (MSfus),
a half HsdS which dimerised to produce a ‘complete’ HsdS
subunit (M1/2S) and a fusion of the half HsdS to HsdM
which also dimerised (M1/2Sfus) were all active MTases and,
when complemented with HsdR, active restriction endonu-
cleases. The modification was efficient in vivo as shown by
the eop assay and the high motif coverage observed in the
SMRT sequencing results. The target sites were as predicted
from knowledge of the TRD specificity although the num-
ber of base pairs separating the methylation sites was in-
creased by one base pair. The restriction in vivo was poor
given the number of targets on phage  (12 for ACCNNN
NNRTGA and 14 for ACCNNNNNGGT) but in line with
previous results with the Type I RM systems from S. au-
reus being expressed in E. coli (25–27). The observed eop
for the restriction positive strains is poor when compared
to the much higher levels of cutback observed with, for ex-
ample, the EcoKI Type I RM system (eop= 10−5 typically)
(42). This poor eop may be due to poor protein stability,
inadequate expression of the HsdR subunits compared to
the MTase subunits or a lack of target sites on the phage.
Given the number of targets on phage  for these enzymes
it is more probable that poor stability, especially for M1/2S,
and a mismatch in the intracellular concentrations of the
HsdR and MTase proteins is responsible for the poor eop.
An unexpected result was observed in the new palin-
dromic sequence, recognised by the dimerising M1/2S and
M1/2Sfus fusion proteins. The sequence is a nucleotide
shorter than that recognised by the wild-type enzyme, but
the methylated bases are one bp further apart. This effect
was not seen in the half HsdS enzymes created by others
(28,29). The main role of the central conserved region has
been assumed to be in separating the TRDs to a specific dis-
tance to recognise the bipartite target sequence but the new
target spacing suggests that there is not a simple relation-
ship between the length of the central conserved region and
the DNA target.
In theory, one final step could be taken to fuse the nucle-
ase domain of HsdR to the M1/2Sfus fusion protein to give
an arrangement of domains identical to a Type IIGRM en-
zyme shown in Figure 1A. Our results would suggest that
such a protein would be expressed and active as a MTase
but that the nature of the fusion of the nuclease domain to
MTase would need much optimisation in the laboratory to
produce a fully functional RM enzyme. Over long evolu-
tionary time periods, Nature has presumably made many
attempts to make the Type IIG RM enzymes by fusing the
nuclease domain of HsdR to the M1/2Sfus fusion protein.
Most of these fusions have failed to function and been elim-
inated but at least one attempt must have succeeded and
spread through bacterial populations such that today Type
IIG RM systems are almost as prevalent as the Type I RM
systems, Table 3.
A structural model for the evolution of RM systems
This work aimed to alter a Type I RM system to structural
forms resembling ‘simpler’ Types of RM systems to provide
evidence for the theory that the RM Types are evolutionar-
ily linked. The Type I, IIG and III systems are by far the
most common RM systems in bacteria and archaea and
are well conserved in terms of genetic structure and pro-
tein structure reusing the same domains in different com-
binations (5,8,16,70), Figure 1A. Table 3 shows the relative
proportions of the different RMTypes with Type I, IIG and
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Table 2. SMRT results determining the sites of methylation on the genomic DNA of E. coli ER2796 using cells transformed with plasmids expressing the
wild type CC398MTase, MSfus, M1/2S or M1/2Sfus proteins. MSfus recognises the same target as the CC398MTase as expected but also modifies some sites
with the second part of the site having the sequence HRTGG rather than RTGA
Enzyme Motifs
m6A modified
position
% Motifs
detected
Number of
motifs detected
Number of
motifs on
genome
CC398 MTase ACCNNNNNRTGA 1 99.69 971 974
TCAYNNNNNGGT 3 99.69 971 974
MSfus ACCNNNNNRTGA 1 76.88 1663 2163
ACCNNNNHRTGG 1 69.46 523 753
TCAYNNNNNGGT 3 76.05 1645 2163
M1/2S ACCNNNNNGGT 1 78.64 2095 2664
M1/2Sfus ACCNNNNNGGT 1 99.66 2655 2664
Table 3. The number of restriction enzymes, both confirmed and putative, in REBASE as at April 2018. The numbers were derived by simply counting
the number of R subunits for the Type I RM systems, the number of REases for the Type II systems and Type IV systems and the number of res subunits
for the Type III RM systems. The proportions are very similar to those obtained previously by Oliviera et al., (5)
RM system Number of examples Percentage of total Percentage of total ignoring Type IV
Type I REase 18580 26.6 31.8
Type IIP REase 13648 19.6 23.4
Type II REase (not IIP or IIG) 7144 10.2 12.2
Type IIG REase/MTase 11737 16.8 20.1
Type III REase 7305 10.5 12.5
Type IV REase 11356 16.3 -
Total 69770 100 100
III making up∼55% of known and putative RM systems in
REBASE (6). The methylation-dependent Type IV restric-
tion systems make up a further 16% leaving the most well-
known Type IIP plus Type IIS and other unassigned Type
II RM systems to make up the remaining∼30% of RM sys-
tems.
Our results linking different Types of RM system suggest
an evolutionarymodel for the diversity ofRMenzymes. The
model, shown in Figure 3, is based upon suggesting answers
to the questions posed in the introduction and makes spe-
cific proposals for experimental tests as described below.
When did RM first appear in evolutionary history and
why did it appear?
It would seem very probable that RM systems appeared
as soon as horizontal gene transfer (HGT) between early
cells arose and they came in contact with the first phage or
other mobile genetic elements (71–74). RM would help any
host cell to control the rate of uptake of foreign DNA and
this would probably be crucial to generate stability in the
primitive genome. If HGT was not controlled, then it is dif-
ficult to see how a stable genome could be established and
maintained in an environment with a lot of mobile genetic
elements (MGE). Conversely too much control of HGT
would slow down the subsequent evolution of the RM host
as no foreign DNA on MGE could enter the host which
would then have to rely solely upon vertical evolution.
What did the first RM system look like?
The first RM system would have to be constructed from
whatever components were present in the early cell. It seems
to us to be highly improbable that classical Type IIP RM
systems with separate REase andMTase enzymes using en-
tirely different chemistries to perform their separate reac-
tions while recognising the exact same DNA target would
evolve easily. The classical Type IIP RM systems are not
‘simple’ systems despite their small size in molecular weight
terms.
We suggest that the first RM enzyme would be akin to a
Type I RM enzyme as the subunits for these enzymes have
close homologues in ancient essential enzymes and proteins
vital for genome repair, nucleotide modification and regula-
tion of transcription. When an early cell evolved a primitive
RM defense system, it would have to build upon the com-
ponents already present. Maintenance of an early genome
would require DNA repair enzymes and these frequently
contain ATP-dependent DEAD-box SFII superfamily pro-
teins of which HsdR is a member (75). Nucleotide methyla-
tion utilises an ancient SAM-dependent fold and this fold
is found in the MTases used in all RM systems (76,77).
Gene regulation using transcription factors to recognise
long palindromic sequences often use homodimeric pro-
teins perhaps akin to the dimers of half-HsdS. For instance,
the BmrR repressor recognises split DNA targets similar
to the targets recognised by the Type I RM systems con-
taining half-HsdS and its structure is strikingly similar to
HsdS (78). When under attack from phage, any early cell
that could assemble an RM system from these components
would have an advantage.
Why did it subsequently evolve to form the large range of
RM structural variants observed today?
This early ‘Type I’ RM enzyme built from pre-existing
components would subsequently evolve to form other ‘sim-
pler’ RM systems by the sorts of domain fusions/deletions
investigated in this work and elsewhere (28,29) under
the evolutionary pressure of antirestriction (79–81). Most
antirestriction / antimodification (anti-RM) systems are
known to be directed at the Type I RM systems (79). These
anti-RM systems, such as DNA mimics (81), would pro-
vide the evolutionary pressure to force the early ‘Type I’
RM system to evolve to an anti-RM-resistant form. These
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Figure 3. Schematic diagram delineating the steps that could be taken to alter the structure of a Type I RM system to create Type II systems. The colour
scheme for domains is the same as in Figure 1. In the step from Nuc1/2S to Nuclease, the domains are merging together so are shown with hatching.
anti-RM-resistant forms would, by definition, be the Type
II and Type III RM systems. It appears the Type II and
Type III RM systems are not targeted by the existing DNA
mimics but this clearly needs further investigation as so
few have been tested for inhibition by a DNA mimic (82).
The first step in this ‘simplification’ of the structure of
the RM enzyme would appear to be via the evolution of
the Type IIB and IIG RM enzymes by the gene fusions
and deletions investigated here. Once a cell had evolved a
RM system resistant to the MGE-borne DNA mimics, the
MGE would then be under further pressure to evolve new
anti-RM mechanisms and it appears that target site avoid-
ance and nucleotide modifications are particularly preva-
lent choices (79,83).
What was the evolutionary pathway for the appearance
of these structural variants?
If the proposed scenario is at least approximately correct
thenwhat happened after the appearance of the Type IIB/G
enzymes to generate the Type IIP andType III RM systems?
Type III RM systems, composed of ‘res’ and ‘mod’ sub-
units (9), would appear to use a variant of the HsdR sub-
unit plus a fused HsdM-HsdS where there has been some
circular permutation to move the hsdS to within the hsdM
gene (17,18,43,53). The relative locations of the TRD with
respect to the motifs for SAM binding subdivide all SAM-
dependent MTases into six groups,  to  , with the  group
predominating (17,43). This circular permutation, with dif-
ferent relative locations of the amino acid motifs of the
SAM-binding domain with respect to the TRD, has also oc-
curred in some Type II RM systems with separate MTases
leading to the formation of  and  subgroups from the 
subgroup, which is the main subgroup in the Type I and
IIB/G RM systems (17,43,84).
To generate separate REase andMTase as found in ‘clas-
sical’ Type IIP RM systems would require a gene duplica-
tion of the nascent Type IIG gene followed by evolution of
the REase by deletion of the M domain and evolution of
theMTase by loss of the nuclease domain and in both cases
retaining the TRD(s), Figure 3. At this point, due to the
selfish nature of RM systems with separate R and M (11),
the MTase would be under pressure to maintain sequence
specificity while the REase could start to mutate to obscure
the amino acid conservation present immediately after the
duplication event. The REase could even acquire new func-
tions (3).
Of course, one may ask why the Type IIP REase has
two ‘TRD’ regions to recognise a palindromic target while
the cognate MTase has only a single different TRD? This
would seem to be a problem with our model. However, very
few RM systems have structures known for both REase
and MTase (PvuII seems to be the only pair apart from
those with combined R and M) (85,86) and there is a re-
grettably little information on the quaternary structure of
the active enzymes. Of note here is that many simple Type
II MTases appear to exist as dimers despite the fact that
they are usually assumed to operate as monomers (44). A
dimeric MTase may have two TRDs but only use one at a
time as this would allow them to simultaneously scan both
DNA strands or tomove around onDNAviaDNA looping
(87). Furthermore, many REases appear to require rather
complicated quaternary structures to assemble on DNA to
be active (88–92). Recent structures of some REases show
distinct similarity to an HsdS subunit (54) and this would
support our suggestion that a proto-IIG enzyme lost its
MTase domain resulting in a fusion of a nuclease domain
to a half-HsdS domain which would then dimerise to pro-
duce a IIPREase with a homodimeric structure and a palin-
dromic target (the cognate MTase would lose the nuclease
domain instead). One of these REases, R.SwaI, recognises
5′-ATTTAAAT-3′ and the two long alpha helices forming
the dimer interface have their helical axes almost perpen-
dicular to the DNA helical axis (54), Supplementary Fig-
ure S8. This arrangement places the two nuclease domains
close to the centre of the target to allow cutting at the centre
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/46/17/9067/5084849 by Edinburgh U
niversity user on 22 January 2020
Nucleic Acids Research, 2018, Vol. 46, No. 17 9077
to produce blunt ends. A similar arrangement is found with
R.HincII which recognises GTYRAC and makes a blunt
cut (91,92), Supplementary Figure S8. In comparison,mod-
els of HsdS bound to DNA (22,24) have the equivalent al-
pha helices aligned nearly parallel with theDNAhelical axis
and this places the TRDs far apart to allow recognition of
the classic bipartite Type I target sequence, Supplementary
Figure S8. Perhaps by changing the angle between helical
axes of the alpha helices and the DNA helix, Nature has
been able to bring theDNA recognition domains of a proto-
half-HsdS closer together to recognise shorter targets and to
incorporate the necessary features of the nuclease domain
to facilitate DNA cleavage? Even Type IIP REases without
such an obvious structural relationship to an HsdS use ex-
tensive alpha helical regions to form the interface between
the two subunits in a similar manner to the interface formed
between two half-HsdS monomers (12).
Our model may also suggest why C5C methylation uses
a very highly conserved MTase domain and why it is found
predominantly in Type II MTases and hardly ever in other
RMTypes. Type I, IIB and IIGMTases, almost without ex-
ception, are N6A or N4CMTases (93). Some are capable of
methylating both as they can be tricked intomethylating the
wrong nucleotide (85) but they do share a common MTase
domain architecture which is very ancient (76). The MTase
N6A/N4C catalytic domain, although having relatively few
conserved amino acid motifs, has a well conserved fold and
catalytic site (7,43,70). TheMTase domain in a C5CMTase
has exactly the same fold as the N6A and N4C MTases
but the amino acid sequence is much better conserved and
10 motifs, including motifs equivalent to those in N6A and
N4C MTases, are easily recognised (7,43,70). This suggests
that C5C methylation is a more recent innovation in evolu-
tion and that it is a difficult chemistry to evolve as it would
require multiple, simultaneous amino acid changes in a pre-
cursor N4C MTase domain (12). Thus, C5C methylation
chemistry probably appeared once and, by chance, became
the main methylation found in eukaryotes.
Further experiments suggested by the structural model
Previously evolutionary models have been proposed for the
Type II RM systems (17,95,96) and similarities between sev-
eral subgroups of the Type II RM systems and the Type I
and III RM systems have been noted (7,8,45–49). However,
when our results are coupled with these evolutionary mod-
els it is possible to suggest a ‘global’ model the majority of
the defined ‘Types’ of RM system (excepting the Type IV re-
striction systems). Of course, our model shown in Figure 3
is not all-encompassing as there are other Type II RM vari-
ants such as IIS and those using other nuclease chemistries
which exist, but these are a small proportion of the total
number of RM systems (5,6). However, our model covers
the great majority of known RM systems (5).
The model, even if subsequently proven to be incorrect,
highlights several areas of RM research that have been ne-
glected and which should be investigated. These areas are
listed below. All of these suggestions are readily addressed
due to easy availability of purified commercial RM en-
zymes.
Perhaps surprisingly, there are very few structures of
REases and MTases from the same RM system (85,86).
More RM ‘pairs’ from Type IIP RM systems should be
solved to see if they use similar structural features to recog-
nise their DNA target sequence. In other words, do the sep-
arate REase and MTase show any sign of a conserved an-
cestral TRD?
Anti-RM DNA mimics have never been tested against
the majority of RM systems other than the Type I RM
systems (82). Given the commercial availability of many
REases and MTases, anti-RM versus the Type II RM en-
zymes could also easily be investigated to see if the DNA
mimics targeting the Type I RM enzymes are more versa-
tile than currently assumed. The phage T7 ocr DNAmimic
(97,98) and the ArdA DNA mimic from conjugative plas-
mids and transposons (56,57,99) could be easily employed
for this purpose but further anti-RM proteins such as T3
SAMase (100), Ral (101) and Lar (102) could be investi-
gated.
The quaternary structure of the RM enzymes when
bound to DNA needs to be examined as, in the few exam-
ples studied, drastic changes in their structure upon binding
have been observed (91). Electron microscopy would seem
to be a particularly useful technique in this area (91), es-
pecially if applied to the large protein-DNA complexes re-
quired for the REase activity of the Type IIB RM enzymes
(89). Atomic forcemicroscopy, although of lower resolution
than electronmicroscopy, may also be useful for elucidating
DNA topology in these complexes (90,103–105).
The evolution of methylation of cytosine at the C5 posi-
tion is clearly difficult as it appears to have only occurred
relatively recently and only in the Type II RM systems. As-
suming that the predecessor of C5C methylation was N4C
methylation, it may be possible to mutate the catalytic site
in a N4C MTase to recognise and methylate C5C (or vice
versa which may be an easier experiment to pursue in prac-
tice) with a few amino acid changes. In this vein, and as sug-
gested by the structure of the SwaI REase (54), it may also
be possible to mutate a TRD in aMTase or HsdS subunit to
incorporate the PD-(D/E)XK nuclease motif and generate
a new REase.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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